Integrated Management of Atypical Parkinsonism: A Home-based Patient-Centered Healthcare Delivery Based on Telenursing (IMPACT Study)

NCT05792332 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 164

Last updated 2026-03-27

No results posted yet for this study

Summary

This project aims to investigate whether an integrated model based on proactive and reactive telenursing monitoring coordinated by a parkinsonism nurse specialist (case manager) is able to improve care delivery and quality of life of patients with atypical parkinsonisms. This could reduce the risk (e.g. through health education counselling) and the severity of complications (e.g. falls). Main responsibilities of the Co-PI: project idea and supervision, coordination of the study, patient selection and recruitment, patient recruitment, participation in statistical analysis and drafting the manuscript. Co-PI is responsible of the rate of recruitment and drop-out

Conditions

  • Atypical Parkinsonism
  • MSA - Multiple System Atrophy
  • PSP
  • Nurse-Patient Relations
  • Nurse Physician Relations

Interventions

OTHER

Telemonitoring

Patients are followed up by a nurse specialist in parkinsonism who interacts with the treating neurologist and a multidisciplinary team

OTHER

Standard-of-care

Patients are managed only by the neurologist according the institution's clinical practice

Sponsors & Collaborators

  • Fondazione Mondino

    collaborator OTHER
  • Neuromed IRCCS

    collaborator OTHER
  • Azienda Ospedaliera Universitaria Policlinico "G. Martino"

    collaborator OTHER
  • Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

    lead OTHER

Principal Investigators

  • Roberto Eleopra, MD · Study Principal Investigator Fondazione IRCCS Istituto Neurologico Carlo Besta

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-17
Primary Completion
2026-06-30
Completion
2026-06-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05792332 on ClinicalTrials.gov